NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.9K citations

Medicine, Oncology, Pharmacotherapy +16

A phase II study

Philippe Rougier, Antoine Adenis, Michel Ducreux et al. · European Journal of Cancer · 2000 · 752 citations

Public Health, Biostatistics, Experimental Design +4

Acute hepatitis induced by greater celandine (Chelidonium majus)

J Benninger, H. T. Schneider, Detlef Schuppan et al. · Gastroenterology · 1999 · 175 citations · Full text

Pharmacy, Internal Medicine, Toxicology +11

A phase II trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancer

Helmut Oettle, M. Arning, Uwe Pelzer et al. · Annals of Oncology · 2000 · 53 citations · Full text

Medicine, Oncology, Pharmacology +14

Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine

Gabriela Kornek, Richard Pötter, Edgar Selzer et al. · International Journal of Radiation Oncology*Biology*Physics · 2001 · 35 citations

Medicine, Oncology, Surgery +8